Novo Nordisk Foundation increases support for humanitarian initiatives
Since 2014, the Novo Nordisk Foundation’s humanitarian grants have directly affected 800,000 people in disadvantaged regions of the world. Thematic priorities and strategic partnerships are increasingly paving the way for focused efforts to improve the future prospects of young refugees and other vulnerable adolescents and to combat the spread of noncommunicable diseases.
From 2014 to 2019, more than 800,000 people in disadvantaged regions of the world have benefitted from humanitarian initiatives supported by the Novo Nordisk Foundation.
New analysis that measures the impact of projects for which the Foundation has awarded grants shows that, during the same period, the Foundation supported 55 acute humanitarian interventions in both natural and human-made emergencies, such as floods, earthquakes and wars. The Foundation awarded 40 of these project grants during 2018 and 2019.
Since 2019, in addition to supporting emergency relief efforts, the Foundation has focused on two special priorities in its humanitarian grants. One is to improve the future prospects of young refugees and other vulnerable adolescents in areas and countries affected by the conflict in Syria, with the projects currently taking place in Jordan. The second priority is to combat noncommunicable diseases in the same region and in eastern Africa, with the projects currently taking place in Jordan and Tanzania.
The thematic priorities are backed by several strategic partnerships that the Foundation established in 2019 with UNICEF, the Danish Refugee Council and the World Diabetes Foundation.
Most recently, through these strategic partnerships, the Foundation has allocated a total of DKK 20 million for four projects to help mitigate the risk of transmission of COVID-19 in Jordan and Tanzania.
“Focusing the efforts geographically and thematically enables us to support organizations and projects that can really make a difference – also in the long term. Combined with our continued support for emergency humanitarian interventions throughout the world, we have the opportunity to both support the development of a long-term presence in selected countries and help out in the world’s hot-spots when the need arises,” says Hanna Line Jakobsen, Senior Vice President, Social & Humanitarian, Novo Nordisk Foundation.
About the Novo Nordisk Foundation
The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. It has two objectives: 1) to provide a stable basis for the commercial and research activities of the companies in the Novo Group; and 2) to support scientific, humanitarian and social causes.
The vision of the Foundation is to contribute significantly to research and development that improves the lives of people and the sustainability of society. Since 2010, the Foundation has donated more than DKK 25 billion (€3.3 billion), primarily for research at public institutions and hospitals in Denmark and the other Nordic countries as well as research-based treatment and prevention of diabetes. Read more at www.novonordiskfonden.dk/en.